TVRD
Tvardi Therapeutics, Inc.
1.10$
-1.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -403.7% | -578.2% | -1,426.4% | -1,255.0% | -547.1% | -332.2% | -299.3% | – | – | – | – | – | – | |
| 10.7% | 2.7% | 2.0% | 7.8% | 2.9% | 1.6% | 0.9% | – | – | – | – | – | – | |
| – | 2.8% | 156.7% | -321.4% | 3.1% | 5.4% | 3.1% | – | – | – | – | – | – | |
| 95.3% | 335.1% | -228.8% | 215.8% | -413.3% | 397.1% | -142.5% | – | – | – | – | – | – | |
| 6.6% | 68.3% | 39.2% | 21.2% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | |
| 475.9% | -1,005.5% | 1,215.5% | 1,542.9% | 97.8% | 343.6% | -423.6% | – | – | – | – | – | – | |
| 22.9% | 1,214.2% | -32.1% | -61.6% | -27.2% | 1,856.3% | -62.4% | – | – | – | – | – | – | |
| 95.1% | -369.5% | -243.0% | 226.3% | -417.8% | -477.5% | -785.3% | – | – | – | – | – | – | |
| -410.4% | -646.5% | -1,465.5% | -1,276.2% | -547.1% | -332.2% | -299.3% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.